Business Wire

VA-VIRTUSTREAM

9.10.2020 13:02:06 CEST | Business Wire | Press release

Share
Virtustream Announces xStreamCare Services™ for Security and Compliance, Enabling Customers to Reduce Risks and Achieve More Proactive Security Posture

Virtustream, an enterprise-class cloud company and Dell Technologies business, announced xStreamCare Services for Security and Compliance today, bringing together advanced security management and monitoring, expert consulting services, and its innovative Trust Platform – a unified, security and compliance management platform.

Virtustream’s latest security solutions provide near real-time visibility into security alerts, intrusion attempts, open vulnerabilities, log analytics, policy management and entitlements across Virtustream’s Enterprise Cloud and Healthcare Cloud platforms, enabling enterprises to achieve a more proactive security posture to protect their business’ IT assets, applications and data.

“Setting the standards of excellence is important to our team at Benjamin Moore. Not only for our products and color offerings, but also for IT security,” said Syed Haider, Director of IT Security, Benjamin Moore. “Virtustream’s deep cloud expertise and focus on understanding our business’ needs make it an excellent fit for us. And by leveraging Virtustream’s new Trust Platform and comprehensive security services – with clear visibility all in one place – we can seamlessly address any issues or risks that may arise.”

For most customers, deploying security services is a manual process, typically managed through multiple platforms. This can be time-consuming, complex and expensive. Without a means to consolidate security data, enterprises struggle to identify their security, compliance and business risks as a whole. In fact, a recent study by Ponemon Institute1 found that 56% of businesses say data breaches occur because of a lack of visibility into the operations of their security programs.

“Our comprehensive approach to security is built on more than a decade of mission-critical cloud experience. With our new security offerings, you can eliminate the need to internally manage the growing number of complexities, cyberattacks and regulatory requirements,” says Pritesh Parekh, Chief Trust & Security Officer at Virtustream. “Our xStreamCare Services for Security and Compliance allow our customers to attain a more robust proactive security posture with unified, near real-time visibility, enabling them to quickly set priorities and make more informed security decisions with precision.”

Unified View Delivers Enhanced Insights and Faster Response Times

Virtustream’s Trust Platform aggregates and automates security data into a unified dashboard. The platform’s simplified and comprehensive view eliminates the need to manually aggregate and process logs from multiple tools and services by providing a clean, near real-time view of an enterprise’s security posture, compliance and risk across multiple workloads.

Virtustream’s Trust Platform is based on the company’s decade of experience securing mission-critical data and applications in the cloud. Further setting the new solution apart from other industry offerings are advanced features, including:

Alerts Dashboard : Displays security alerts with sensitivity levels that originate from Virtustream-deployed security controls with the ability to drill down, filter, and export data.

Vulnerability Dashboard : Prompts proactive protection through awareness of open vulnerabilities as well as their severity and age. Authorized users can define and manage aging and remediation policies.

Log Analytics : Enables ad-hoc queries against aggregated security and OS logs.

Policy Management: Supports customer-defined policies for managing security vulnerabilities.

Compliance Reporting : Allows on-demand download of available reports such as Type 2 SOC 2 + HITRUST with Cloud Security Alliance (CSA) Cloud Controls Matrix and Type 2 Attestation (AT-C 105 and AT-C 205) HIPAA/HITECH.

Asset Management Dashboard : Catalogs all assets in the cloud along with the status of security services.

The Trust Platform is available today on Virtustream Enterprise Cloud and Virtustream Healthcare Cloud.

Security Services for Every Businesses’ IT Needs

The combination of robust security features with actionable visibility helps block attacks proactively before they can penetrate a secure environment. Using security services for cloud-hosted mission-critical applications can also help increase the internal security operation team’s productivity. By off-loading management, internal IT teams can reduce the daily burden of managing security operations. Internal teams can also leverage on-demand access to certified cybersecurity experts and consulting services to address a range of potential internal skills gap.

The Security Essentials Bundle includes anti-virus/anti-malware, host intrusion detection system (IDS), host firewall, host file integrity monitoring, log management and vulnerability scanning. The Security Healthcare Bundle includes all services from the Essentials set as well as data at rest encryption and network intrusion detection. And the Enhanced Bundle includes all of these services along with log forwarding, network firewall policy auditor, data at rest encryption, operating system hardening scans, and SAP virus scanning services.

Find more information on Virtustream Enterprise Cloud , Virtustream Healthcare Cloud , the Trust Center , and on xStreamCare Services for Security and Compliance .

About Virtustream

Virtustream LLC, a Dell Technologies Business, is the enterprise-class cloud company that is trusted by organizations worldwide to migrate and run their mission-critical applications in the cloud. For enterprises, service providers, healthcare organizations and government agencies Virtustream’s xStreamCare Services™ expertise combined with the Virtustream xStream® Management Platform and Infrastructure-as-a Service (IaaS) meets the security, compliance, performance, efficiency and consumption-based billing requirements of complex production applications in the cloud – whether private, public or hybrid.

Virtustream is a trademark of Virtustream LLC. Other trademarks may be trademarks of their respective owners.

1) “The Cybersecurity Illusion: The Emperor Has No Clothes,” by Ponemon Institute, published in July 2019, cited here on Nov. 6, 2019.

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

SOLUM and Simbe Expand European Collaboration to Advance Intelligent Store Operations5.3.2026 08:00:00 CET | Press release

SOLUM (KOSPI: 248070) and Simbe announced the expansion of their strategic collaboration to further integrate autonomous store intelligence with SOLUM’s Newton Electronic Shelf Label (ESL) infrastructure across Europe. The collaboration was highlighted at EuroShop, where Simbe’s Store Intelligence™ platform was demonstrated live at the SOLUM booth. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260304620371/en/ SOLUM and Simbe announced the expansion of their strategic collaboration to further integrate autonomous store intelligence with SOLUM’s Newton Electronic Shelf Label (ESL) infrastructure across Europe. (Image: SOLUM) Simbe recently introduced Tally 4.0, the next generation of their autonomous shelf-scanning robot, reflecting the company’s continued evolution in retail shelf digitization, incorporating extended runtime, enhanced edge computing, and advanced vision capabilities. Designed to deliver deeper shelf coverag

Mosaic Clinical Technologies Announces FDA Breakthrough Device Designation for Cognita’s Generative AI Model for Radiology5.3.2026 08:00:00 CET | Press release

Breakthrough designation means Cognita™ will engage in prioritized interaction with FDA regarding clearance of device designed to help solve the radiology capacity bottleneck Mosaic Clinical Technologies™, a wholly-owned subsidiary of Radiology Partners, is pleased to announce that Cognita™, its AI business unit developing generative vision-language models (VLMs) for radiology, has received U.S. Food and Drug Administration (FDA) Breakthrough Device Designation for Cognita Chest X-Ray (CXR)™1 across multiple critical indications. Cognita CXR is an industry-first generative vision-language model designed to assist radiologists in the interpretation of chest X-rays and is the first radiology generative AI model, and one of very few radiology AI solutions, to be granted this designation2. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260304633206/en/ Cognita™ operates as the AI business unit of Mosaic Clinical Technologies™, a

Cielo Advances Resilient Remote Connectivity for Its Nationwide Payment Terminal Fleet With Thales5.3.2026 08:00:00 CET | Press release

Cielo, one of Brazil’s leading payment service providers, is piloting remote connectivity management for its point-of-sale (POS) terminals across the country, in partnership with Thales. By deploying Thales’s eSIM connectivity management platform based on the latest GSMA SGP.32 IoT standard, Cielo is accelerating its transition from manual, on-site SIM management to fully remote, secure and resilient connectivity. For Cielo, connectivity is mission critical. When payment terminals lose network access, transactions stop. To strengthen operational resilience and enhance merchant experience, Cielo is modernizing its connectivity architecture across its terminal fleet. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260304089321/en/ Cielo advances resilient remote connectivity for its nationwide payment terminal fleet with Thales. Using Thales’s eSIM technology as part of this strategy, Cielo can remotely switch mobile network op

GAIA and Daiichi Sankyo Europe Enter Exclusive Partnership to Launch Next-Generation Digital Therapeutic for Cardiovascular Care in Europe.5.3.2026 08:00:00 CET | Press release

GAIA, the pioneer in evidence-based digital therapeutics and Daiichi Sankyo Europe, today announced an exclusive strategic partnership to commercialize lipodia upon regulatory approval1. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260224658973/en/ Dr. Mario Weiss, Founder & CEO of GAIA AG This digital therapeutic is designed to support adults living with hypercholesterolemia. The comprehensive collaboration brings together GAIA’s long-standing expertise in developing clinically validated non-pharmacological interventions with Daiichi Sankyo’s highly scientific experience in cardiovascular risk management and health. Together, the partners - both members of the German Association of Research-Based Pharmaceutical Companies (vfa) - aim to address a persistent gap in chronic care: leveraging digital technologies to make a difference in patients’ lives by supporting sustainable, long-term behaviour change. Expanding Cardiovasc

Galderma Delivers Record 2025 Results With Net Sales of 5.207 Billion USD, up 17.7% at Constant Currency1, and Core EBITDA2 of 1.211 billion USD, Growing 18.9% at Constant Currency5.3.2026 07:00:00 CET | Press release

Ad hoc announcement pursuant to Art. 53 LR Galderma Group AG (SIX:GALD), the pure-play dermatology category leader, today announced its financial results for the full year 2025. Record net sales of 5,207 million USD, surpassing 5 billion USD in a year for the first time and representing 17.7% year-on-year growth on a constant currency1 basis, primarily driven by volume. Broad-based net sales growth, growing double-digits in both International markets and the U.S. Outperforming the market in each product category, with strong net sales growth in Injectable Aesthetics (11.5%), Dermatological Skincare (9.3%) and Therapeutic Dermatology (50.2%), all year-on-year at constant currency. Strong launch momentum across future growth drivers, including Nemluvio® (nemolizumab) delivering 452 million USD in net sales; Relfydess™ (RelabotulinumtoxinA) outperforming expectations in 17 International markets; Sculptra® gaining significant market share in its first year in China; and continued new produ

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye